全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1333002-37-1 | 1-Bromo-9-phenyl-9H-carbazole | C18H12BrN |
| 1333151-73-7 | (2Z)-3-[3-[3-Methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 1-methylethyl ester | C16H16F3N3O3 |
| 1333154-10-1 | 5-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazole | C10H5F6N3 |
| 1333231-43-8 | N-[(1S)-1-[[[(1S)-1-(Hydroxymethyl)-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]carbamic acid phenylmethyl ester | C21H31N3O5 |
| 1333317-99-9 | Poly[[(2,4,6-trimethylphenyl)imino][1,1'-biphenyl]-4,4'-diyl];PTAA | (C21H19N)n |
| 1333323-17-3 | 10-Deacetylyunnanxane;[(1S,2S,3S,5S,8S,10S,14S)-2,5-diacetyloxy-10-hydroxy-8,12,15,15-tetramethyl-4-methylidene-14-tricyclo[9.3.1.03,8]pentadec-11-enyl] (2R,3S)-3-hydroxy-2-methylbutanoate | C29H44O8 |
| 1333377-65-3 | 3-(1H-Indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine;CHR 6494 | C16H16N6 |
| 1333390-56-9 | Regorafenib Urea Impurity;1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea | C14H9ClF4N2O2 |
| 1333995-14-4 | Aprepitant Impurity 5 HCl;(2S,3S)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride | C20H18F7NO2 .HCl |
| 1333998-21-2 | Des-1,2,4-triazol-3-one-5-methyl (2R,3R,2-(S))-Aprepitant Hydrochloride;(2R,3R)-2-{(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine hydrochloride (1:1) | C20H19ClF7NO2 |
| 1333998-27-8 | Fosaprepitant Morpholine Hydrochloride;(2S,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine;hydrochloride | C20H19ClF7NO2 |
| 1334172-76-7 | (3aS,4S,6aR)-N-(23-Amino-3,6,9,12,15,18,21-heptaoxatricos-1-yl)hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | C26H50N4O9S |
| 1334177-86-4 | 1-Maleimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-aza-hentriacontan-31-oic acid;3-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid | C26H44N2O13 |
| 1334179-85-9 | 2-[4-[(Bis[(1-tert-butyl-1H-1,2,3-triazol-4-yl)methyl]amino)methyl]-1H-1,2,3-triazol-1-yl]acetic acid;BTTAA | C19H30N10O2 |
| 1334294-43-7 | 6-Chloro-4-(4-morpholinylmethyl)-2-pyridinamine | C10H14ClN3O |
| 1334298-90-6 | Itacitinib;INCB 039110; 1-[1-[[3-Fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile | C26H23F4N9O |
| 1334302-63-4 | Hexanedioic acid, compd. with 1-[1-[[3-fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile (1:1) | C26H23F4N9O.C6H10O4 |
| 1334493-07-0 | 4-[[(4-Cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-2-hydroxybenzoic acid;BP 1-102 | C29H27F5N2O6S |
| 1334497-06-1 | Chloro(crotyl)[di-tert-butyl(4-dimethylaminophenyl)phosphine]palladium(II) | C20H35ClNPPd |
| 1334499-86-3 | 5-Fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester | C10H8FIN2O2 |
| 1334499-90-9 | 5,7-Difluoro-3-iodo-1H-indole-2-carboxylic acid ethyl ester | C11H8F2INO2 |
| 1334509-86-2 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-methyl-L-tryptophan | C27H24N2O4 |
| 1334513-02-8 | N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester | C18H17F5NO5P |
| 1334532-19-2 | (R)-Propionyl Carnitine-d3 Chloride | C10H17D3ClNO4 |
| 1334532-24-9 | Octanoyl L-Carnitine-d3 Chloride | C15H27D3ClNO4 |
| 1334532-25-0 | Myristoyl-L-carnitine-d3 Hydrochloride | C21H39D3ClNO4 |
| 1334532-26-1 | Palmitoyl-L-carnitine-d3 Hydrochloride | C23H43D3ClNO4 |
| 1334547-76-0 | Chloro(2-{bis[3,5-bis(trifluoromethyl)phenyl]phosphino}-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)gold(I) | C39H37AuClF12O2P |
| 1334719-95-7 | 6-Chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]-1-piperidinyl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide;IAP 6; Q 203 | C29H28ClF3N4O2 |
| 1334782-79-4 | 2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | C29H32N6OS |
| 1334890-93-5 | (1,10-Phenanthroline)(trifluoromethyl)(triphenylphosphine)copper(I) | C31H23CuF3N2P |
| 1335054-04-0 | Ethyl 6-bromo-4-chloronicotinate | C8H7BrClNO2 |
| 1335054-80-2 | 2-Bromo[1,2,4]triazolo[1,5-a]pyrimidine | C5H3BrN4 |
| 1335057-22-1 | 5-Bromo-6-chloro-3-nitro-2-pyridinamine | C5H3BrClN3O2 |
| 1335110-44-5 | Rosuvastatin EP impurity H;5-[8-fluoro-2-[methyl(methylsulfonyl)amino]-4-propan-2-yl-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoate;methane | C23H31FN3O6S- |
| 1335202-59-9 | 2-[3-Cyano-4-(1-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid | C16H16N2O3S |
| 1335202-60-2 | 2-Isobutoxy-5-(4-methylthiazol-2-yl)benzonitrile;2-(2-Methylpropoxy)-5-(4-methyl-2-thiazolyl)benzonitrile | C15H16N2OS |
| 1335210-23-5 | 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester | C13H17NO8 |
| 1335210-24-6 | Cabotegravir Intermediate;(3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid | C13H14N2O6 |
| 1335210-26-8 | Methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate | C11H19NO6 |
| 1335210-34-8 | (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid;(3S,7R)-11-methoxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxylic acid | C14H16N2O6 |
| 1335210-35-9 | (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | C21H21F2N3O5 |
| 1335316-40-9 | (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline | C13H22N2O5 |
| 1335523-82-4 | (3S)-3-(4-Bromophenyl)piperidine | C11H14BrN |
| 1337482-15-1 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-3'-uridylyl]-L-alanine 1-methylethyl ester | C22H29FN3O9P |
| 1337531-36-8 | 7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;GSK 2606414 | C24H20F3N5O |
| 1337532-29-2 | 5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C23H21FN6O |
| 1337532-51-0 | 5-Bromo-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C7H7BrN4 |
| 1337879-62-5 | 7-Bromo-4-methoxy-1H-indazole | C8H7BrN2O |
| 1337880-06-4 | 6-Bromo-7-methyl-1H-indazole | C8H7BrN2 |